Skyward Specialty Insurance Group Reports First Quarter 2024 Results
Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) reported a strong first quarter 2024 with net income of $36.8 million, up from $15.6 million in 2023. Highlights include gross written premiums increasing by 27.2%, underwriting income of $24.7 million, and an annualized return on equity of 21.7%. The company continues to execute its strategy successfully and expects to deliver attractive returns for shareholders in 2024.
Net income increased from $15.6 million in 2023 to $36.8 million in the first quarter of 2024.
Gross written premiums rose by 27.2%.
Underwriting income reached $24.7 million.
Annualized return on equity improved to 21.7%.
7 out of 8 underwriting divisions achieved double-digit growth.
Expense ratio increased by 1.3 points in the first quarter of 2024 compared to the same period in 2023.
The loss ratio for the first quarter of 2024 improved by 1.9 points, impacted minimally by catastrophe losses.
Insights
The comprehensive increase in Skyward Specialty Insurance Group's net income, from
As the company's combined ratio remains below
Skyward Specialty's significant leap in net investment income, with a jump of more than
The reported growth in all but one of Skyward Specialty's underwriting divisions, with seven out of eight achieving double-digit growth, demonstrates a strong market position and the successful 'Rule our Niche' strategy. The negligible impact of catastrophe losses (
Additionally, the reported improvement in the current accident year non-cat loss and LAE ratio by
HOUSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today reported first quarter 2024 net income of
Adjusted operating income(1) for the first quarter of 2024 was
Highlights for the quarter included:
- Gross written premiums increased
27.2% . - Underwriting income(1) of
$24.7 million compared to$17.8 million for the first quarter of 2023. - Combined ratio of
89.6% compared to90.2% for the first quarter of 2023. - Current accident year non-cat loss and LAE ratio of
60.6% compared to61.1% for the first quarter of 2023. - Cat loss and LAE ratio of
0.4% compared to1.8% for the first quarter of 2023. - Annualized return on equity of
21.7% compared to13.4% for the same 2023 period. - Annualized return on tangible equity(1) of
25.0% compared to16.6% for the same 2023 period.
| (1) See "Reconciliation of Non-GAAP Financial Measures" |
Skyward Specialty Chairman and CEO Andrew Robinson commented, "We continued to build on our outstanding 2023 results in the first quarter of 2024, delivering an
Results of Operations
Underwriting Results
| Premiums | |||||||||||
| ($ in thousands) | Three months ended March 31, | ||||||||||
| unaudited | 2024 | 2023 | % Change | ||||||||
| Gross written premiums | $ | 458,620 | $ | 360,498 | 27.2 | % | |||||
| Ceded written premiums | $ | (171,520 | ) | $ | (158,357 | ) | 8.3 | % | |||
| Net retention | 62.6 | % | 56.1 | % | NM(1) | ||||||
| Net written premiums | $ | 287,100 | $ | 202,141 | 42.0 | % | |||||
| Net earned premiums | $ | 236,342 | $ | 182,831 | 29.3 | % | |||||
| (1)Not meaningful | |||||||||||
The increase in gross written premiums for the first quarter of 2024, when compared to the same 2023 period, was driven by double-digit premium growth primarily from our captives, transactional E&S, surety, global property & agriculture and professional lines underwriting divisions.
| Combined Ratio | Three months ended March 31, | |||||
| (unaudited) | 2024 | 2023 | ||||
| Non-cat loss and LAE(1) | 60.6 | % | 61.1 | % | ||
| Cat loss and LAE(1) | 0.4 | % | 1.8 | % | ||
| Prior accident year development - non-LPT | 0.0 | % | 0.0 | % | ||
| Prior accident year development - LPT(2) | (0.1)% | (0.1)% | ||||
| Loss Ratio | 60.9 | % | 62.8 | % | ||
| Net policy acquisition costs | 13.6 | % | 11.6 | % | ||
| Other operating and general expenses | 16.0 | % | 16.6 | % | ||
| Commission and fee income | (0.9)% | (0.8)% | ||||
| Expense ratio | 28.7 | % | 27.4 | % | ||
| Combined ratio | 89.6 | % | 90.2 | % | ||
| Adjusted Underwriting Ratios | ||||||
| Adjusted loss ratio(2) | 61.0 | % | 62.9 | % | ||
| Expense ratio | 28.7 | % | 27.4 | % | ||
| Adjusted combined ratio(2) | 89.7 | % | 90.3 | % | ||
| (1)Current accident year | ||||||
| (2)See "Reconciliation of Non-GAAP Financial Measures" | ||||||
The loss ratio for the first quarter of 2024 improved 1.9 points when compared to the same 2023 period. The first quarter of 2024 was minimally impacted by catastrophe losses, while the first quarter of 2023 was impacted by wind and hail events, including tornadoes, which added 1.8 points to the 2023 loss ratio. The non-cat loss and LAE ratio improved 0.5 points when compared to the same 2023 period, primarily driven by the shift in the mix of business.
The expense ratio for the first quarter of 2024 increased 1.3 points when compared to the same 2023 period driven by the business mix shift.
The expense ratios for the first quarter of 2024 and 2023, respectively, exclude the impact of IPO related stock compensation and secondary offering expenses, which are reported in other expenses in our condensed consolidated statements of operations and comprehensive income.
Investment Results
| Net Investment Income | ||||||||
| $ in thousands | Three months ended March 31, | |||||||
| (unaudited) | 2024 | 2023 | ||||||
| Short-term investments & cash and cash equivalents | $ | 5,088 | $ | 1,776 | ||||
| Fixed income | 12,478 | 7,461 | ||||||
| Equities | 627 | (2 | ) | |||||
| Alternative & strategic investments | 104 | (4,589 | ) | |||||
| Net investment income | $ | 18,297 | $ | 4,646 | ||||
| Net unrealized gains on securities still held | $ | 8,991 | $ | 3,767 | ||||
| Net realized losses | (688 | ) | (2,806 | ) | ||||
| Net investment gains | $ | 8,303 | $ | 961 | ||||
Beginning January 1, 2024 we simplified the investment portfolio classifications to align with our strategy and the underlying risk characteristics of the portfolio. The prior period has been reclassified to conform to the current period presentation.
Net investment income for the first quarter of 2024 increased
Stockholders’ Equity
Stockholders’ equity was
Conference Call
At 9 a.m. central time tomorrow, May 2, 2024, Skyward Specialty management will hold a conference call to discuss quarterly results with insurance industry analysts. Interested parties may listen to the discussion at investors.skywardinsurance.com under Events & Presentations. Additionally, investors can access the earnings call via conference call by registering via the conference link. Users will receive dial-in information and a unique PIN to join the call upon registering.
Non-GAAP Financial Measures
This release contains certain financial measures and ratios that are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). We refer to these measures as “non-GAAP financial measures.” We use these non-GAAP financial measures when planning, monitoring, and evaluating our performance.
We have chosen to exclude the net impact of the Loss Portfolio Transfer (“LPT”), all development on reserves fully or partially covered by the LPT and amortization of deferred gains associated with recoveries of prior LPT reserve strengthening in certain non-GAAP metrics, where noted, as the business subject to the LPT is not representative of our continuing business strategy. The business subject to the LPT is primarily related to policy years 2017 and prior, was generated and managed under prior leadership, and has either been exited or substantially repositioned during the reevaluation of our portfolio. We consider these non-GAAP financial measures to be useful metrics for our management and investors to facilitate operating performance comparisons from period to period. While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered supplemental in nature and is not meant to be a substitute for revenue or net income, in each case as recognized in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as comparative measures. For more information regarding these non-GAAP financial measures and a reconciliation of such measures to comparable GAAP financial measures, see the section entitled “Reconciliation of Non-GAAP Financial Measures.”
About Skyward Specialty Insurance Group, Inc.
Skyward Specialty is a rapidly growing and innovative specialty insurance company, delivering commercial property and casualty products and solutions on a non-admitted and admitted basis. The Company operates through eight underwriting divisions - Accident & Health, Captives, Global Property & Agriculture, Industry Solutions, Professional Lines, Programs, Surety and Transactional E&S. SKWD stock is traded on the Nasdaq Global Select Market, which represents the top fourth of all Nasdaq listed companies.
Skyward Specialty's subsidiary insurance companies consist of Houston Specialty Insurance Company, Imperium Insurance Company, Great Midwest Insurance Company, and Oklahoma Specialty Insurance Company. These insurance companies are rated A- (Excellent) with positive outlook by A.M. Best Company. Additional information about Skyward Specialty can be found on our website at www.skywardinsurance.com.
Forward-Looking Statements
Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are typically, but not always, identified through use of the words "believe," "expect," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Skyward Specialty's Form 10-K, and include (but are not limited to) legislative changes at both the state and federal level, state and federal regulatory rule making promulgations and adjudications, class action litigation involving the insurance industry and judicial decisions affecting claims, policy coverages and the general costs of doing business, the potential loss of key members of our management team or key employees and our ability to attract and retain personnel, the impact of competition on products and pricing, inflation in the costs of the products and services insurance pays for, product development, geographic spread of risk, weather and weather-related events, other types of catastrophic events, our ability to obtain reinsurance coverage at prices and on terms that allow us to transfer risk and adequately protect our company against financial loss, and losses resulting from reinsurance counterparties failing to pay us on reinsurance claims. These forward-looking statements speak only as of the date of this release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
Skyward Specialty Insurance Group, Inc.
Media contact:
Haley Doughty
hdoughty@skywardinsurance.com
713-935-4944
or
Investor contact:
Natalie Schoolcraft,
nschoolcraft@skywardinsurance.com
614-494-4988
| Consolidated Balance Sheets | ||||||||
| ($ in thousands, except share and per share amounts) | ||||||||
| (unaudited) | March 31, 2024 | December 31, 2023 | ||||||
| Assets | ||||||||
| Investments: | ||||||||
| Fixed maturity securities, available-for-sale, at fair value (amortized cost of | $ | 1,065,175 | $ | 1,017,651 | ||||
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of | 42,700 | 42,986 | ||||||
| Equity securities, at fair value | 117,083 | 118,249 | ||||||
| Mortgage loans, at fair value | 44,309 | 50,070 | ||||||
| Equity method investments | 103,962 | 110,653 | ||||||
| Other long-term investments | 2,045 | 3,852 | ||||||
| Short-term investments, at fair value | 297,932 | 270,226 | ||||||
| Total investments | 1,673,206 | 1,613,687 | ||||||
| Cash and cash equivalents | 85,059 | 65,891 | ||||||
| Restricted cash | 30,210 | 34,445 | ||||||
| Premiums receivable, net | 273,410 | 179,235 | ||||||
| Reinsurance recoverables, net | 612,043 | 596,334 | ||||||
| Ceded unearned premium | 204,625 | 186,121 | ||||||
| Deferred policy acquisition costs | 104,697 | 91,955 | ||||||
| Deferred income taxes | 23,607 | 21,991 | ||||||
| Goodwill and intangible assets, net | 88,137 | 88,435 | ||||||
| Other assets | 92,063 | 75,341 | ||||||
| Total assets | $ | 3,187,057 | $ | 2,953,435 | ||||
| Liabilities and stockholders’ equity | ||||||||
| Liabilities: | ||||||||
| Reserves for losses and loss adjustment expenses | $ | 1,376,946 | $ | 1,314,501 | ||||
| Unearned premiums | 621,794 | 552,532 | ||||||
| Deferred ceding commission | 41,062 | 37,057 | ||||||
| Reinsurance and premium payables | 193,760 | 150,156 | ||||||
| Funds held for others | 88,864 | 58,588 | ||||||
| Accounts payable and accrued liabilities | 53,443 | 50,880 | ||||||
| Notes payable | 100,000 | 50,000 | ||||||
| Subordinated debt, net of debt issuance costs | 18,916 | 78,690 | ||||||
| Total liabilities | 2,494,785 | 2,292,404 | ||||||
| Stockholders’ equity | ||||||||
| Common stock, | 400 | 399 | ||||||
| Additional paid-in capital | 711,309 | 710,855 | ||||||
| Stock notes receivable | (5,234 | ) | (5,562 | ) | ||||
| Accumulated other comprehensive loss | (29,279 | ) | (22,953 | ) | ||||
| Retained earnings (accumulated deficit) | 15,076 | (21,708 | ) | |||||
| Total stockholders’ equity | 692,272 | 661,031 | ||||||
| Total liabilities and stockholders’ equity | $ | 3,187,057 | $ | 2,953,435 | ||||
| Condensed Consolidated Statements of Operations and Comprehensive Income | ||||||||
| ($ in thousands) | Three months ended March 31, | |||||||
| (unaudited) | 2024 | 2023 | ||||||
| Revenues: | ||||||||
| Net earned premiums | $ | 236,342 | $ | 182,831 | ||||
| Commission and fee income | 2,026 | 1,492 | ||||||
| Net investment income | 18,297 | 4,646 | ||||||
| Net investment gains | 8,303 | 961 | ||||||
| Total revenues | 264,968 | 189,930 | ||||||
| Expenses: | ||||||||
| Losses and loss adjustment expenses | 143,914 | 114,900 | ||||||
| Underwriting, acquisition and insurance expenses | 69,774 | 51,655 | ||||||
| Interest expense | 2,727 | 2,152 | ||||||
| Amortization expense | 388 | 387 | ||||||
| Other expenses | 1,188 | 1,114 | ||||||
| Total expenses | 217,991 | 170,208 | ||||||
| Income before income taxes | 46,977 | 19,722 | ||||||
| Income tax expense | 10,193 | 4,166 | ||||||
| Net income | 36,784 | 15,556 | ||||||
| Net income attributable to participating securities | — | 1,274 | ||||||
| Net income attributable to common stockholders | $ | 36,784 | $ | 14,282 | ||||
| Comprehensive income: | ||||||||
| Net income | $ | 36,784 | $ | 15,556 | ||||
| Other comprehensive (loss) income: | ||||||||
| Unrealized gains and losses on investments: | ||||||||
| Net change in unrealized (losses) gains on investments, net of tax | (5,418 | ) | 7,788 | |||||
| Reclassification adjustment for losses on securities no longer held, net of tax | (908 | ) | (47 | ) | ||||
| Total other comprehensive (loss) income | (6,326 | ) | 7,741 | |||||
| Comprehensive income | $ | 30,458 | $ | 23,297 | ||||
| Share and Per Share Data | ||||||||
| ($ in thousands, except share and per share amounts) | Three months ended March 31, | |||||||
| (unaudited) | 2024 | 2023 | ||||||
| Weighted average basic shares | 39,108,351 | 32,848,243 | ||||||
| Weighted average diluted shares | 41,085,136 | 36,952,073 | ||||||
| Basic earnings per share | $ | 0.94 | $ | 0.43 | ||||
| Diluted earnings per share | $ | 0.90 | $ | 0.42 | ||||
| Basic adjusted operating earnings per share | $ | 0.79 | $ | 0.43 | ||||
| Diluted adjusted operating earnings per share | $ | 0.75 | $ | 0.42 | ||||
| Annualized ROE(1) | 21.7 | % | 13.4 | % | ||||
| Annualized adjusted ROE(2) | 18.3 | % | 13.3 | % | ||||
| Annualized ROTE(3) | 25.0 | % | 16.6 | % | ||||
| Annualized adjusted ROTE(4) | 21.1 | % | 16.5 | % | ||||
| March 31 | December 31 | |||||||
| 2024 | 2023 | |||||||
| Shares outstanding | 39,995,027 | 39,863,756 | ||||||
| Fully diluted shares outstanding | 41,964,170 | 41,771,854 | ||||||
| Book value per share | $ | 17.44 | $ | 16.72 | ||||
| Fully diluted book value per share | $ | 16.62 | $ | 15.96 | ||||
| Fully diluted tangible book value per share | $ | 14.52 | $ | 13.84 | ||||
| (1)Annualized ROE is net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period | ||||||||
| (2)Annualized adjusted ROE is adjusted operating income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period | ||||||||
| (3)Annualized ROTE is net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period | ||||||||
| (4)Annualized adjusted ROTE is adjusted operating income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period | ||||||||
Adjusted operating income – We define adjusted operating income as net income excluding the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We use adjusted operating income as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted operating income should not be viewed as a substitute for net income calculated in accordance with GAAP, and other companies may define adjusted operating income differently.
| ($ in thousands) | Three months ended March 31, | |||||||||||||||
| (unaudited) | 2024 | 2023 | ||||||||||||||
| Pre-tax | After-tax | Pre-tax | After-tax | |||||||||||||
| Income as reported | $ | 46,977 | $ | 36,784 | $ | 19,722 | $ | 15,556 | ||||||||
| Less (Add): | ||||||||||||||||
| Net investment gains | 8,303 | 6,559 | 961 | 759 | ||||||||||||
| Net impact of loss portfolio transfer | 241 | 190 | 242 | 191 | ||||||||||||
| Other expenses | (1,188 | ) | (939 | ) | (1,114 | ) | (880 | ) | ||||||||
| Adjusted operating income | $ | 39,621 | $ | 30,974 | $ | 19,633 | $ | 15,486 | ||||||||
Underwriting income – We define underwriting income as net income before income taxes excluding net investment income, net realized and unrealized gains and losses on investments, impairment charges, interest expense, amortization expense and other income and expenses. Underwriting income represents the pre-tax profitability of our underwriting operations and allows us to evaluate our underwriting performance without regard to investment income. We use this metric as we believe it gives our management and other users of our financial information useful insight into our underlying business performance. Underwriting income should not be viewed as a substitute for pre-tax income calculated in accordance with GAAP, and other companies may define underwriting income differently.
| ($ in thousands) | Three months ended March 31, | |||||
| (unaudited) | 2024 | 2023 | ||||
| Income before federal income tax expense | $ | 46,977 | $ | 19,722 | ||
| Add: | ||||||
| Interest expense | 2,727 | 2,152 | ||||
| Amortization expense | 388 | 387 | ||||
| Other expenses | 1,188 | 1,114 | ||||
| Less: | ||||||
| Net investment income | 18,297 | 4,646 | ||||
| Net investment gains | 8,303 | 961 | ||||
| Underwriting income | $ | 24,680 | $ | 17,768 | ||
Adjusted Loss Ratio / Adjusted Combined Ratio – We define adjusted loss ratio and adjusted combined ratio as the corresponding ratio (calculated in accordance with GAAP), excluding losses and LAE related to the LPT and all development on reserves fully or partially covered by the LPT and amortization of deferred gains associated with recoveries of prior LPT reserve strengthening. We use these adjusted ratios as internal performance measures in the management of our operations because we believe they give our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Our adjusted loss ratio and adjusted combined ratio should not be viewed as substitutes for our loss ratio and combined ratio, respectively.
| ($ in thousands) | Three months ended March 31, | |||||||
| (unaudited) | 2024 | 2023 | ||||||
| Net earned premiums | $ | 236,342 | $ | 182,831 | ||||
| Losses and LAE | 143,914 | 114,900 | ||||||
| Add: Pre-tax net impact of LPT | (241 | ) | (242 | ) | ||||
| Adjusted losses and LAE | $ | 144,155 | $ | 115,142 | ||||
| Loss ratio | 60.9 | % | 62.8 | % | ||||
| Add: net impact of LPT | (0.1)% | (0.1)% | ||||||
| Adjusted loss ratio | 61.0 | % | 62.9 | % | ||||
| Combined ratio | 89.6 | % | 90.2 | % | ||||
| Add: net impact of LPT | (0.1)% | (0.1)% | ||||||
| Adjusted combined ratio | 89.7 | % | 90.3 | % | ||||
Tangible Stockholders’ Equity – We define tangible stockholders’ equity as stockholders’ equity less goodwill and intangible assets. Our definition of tangible stockholders’ equity may not be comparable to that of other companies and should not be viewed as a substitute for stockholders’ equity calculated in accordance with GAAP. We use tangible stockholders’ equity internally to evaluate the strength of our balance sheet and to compare returns relative to this measure.
| ($ in thousands) | March 31 | December 31 | |||||||
| (unaudited) | 2024 | 2023 | 2023 | ||||||
| Stockholders' equity | $ | 692,272 | $ | 507,146 | $ | 661,031 | |||
| Less: Goodwill and intangible assets | 88,137 | 89,503 | 88,435 | ||||||
| Tangible stockholders' equity | $ | 604,135 | $ | 417,643 | $ | 572,596 | |||
FAQ
What was the net income for Skyward Specialty in the first quarter of 2024?
How much did gross written premiums increase by in the first quarter of 2024?
What was the annualized return on equity for Skyward Specialty in the first quarter of 2024?
When will Skyward Specialty hold a conference call to discuss quarterly results?
